Wang S - Search Results

1

Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators.

Wang Z, Liu C, Zheng S, Yao Y, Wang S, Wang X, Yin E, Zeng Q, Zhang C, Zhang G, Tang W, Zheng B, Xue L, Wang Z, Feng X, Wang Y, Ying J, Xue Q, Sun N, He J. Wang Z, et al. Among authors: wang x, wang y, wang s. Cancer Cell. 2024 Jun 10;42(6):1106-1125.e8. doi: 10.1016/j.ccell.2024.05.002. Epub 2024 May 23. Cancer Cell. 2024. PMID: 38788718

2

Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma.

Zhang C, Zhang Z, Zhang G, Zhang Z, Luo Y, Wang F, Wang S, Che Y, Zeng Q, Sun N, He J. Zhang C, et al. Among authors: wang f, wang s. Cancer Lett. 2020 Jun 1;479:31-41. doi: 10.1016/j.canlet.2020.03.016. Epub 2020 Mar 19. Cancer Lett. 2020. PMID: 32201203

3

An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma.

Zhang C, Zhang G, Sun N, Zhang Z, Xue L, Zhang Z, Yang H, Luo Y, Zheng X, Zhang Y, Yuan Y, Lei R, Yang Z, Zheng B, Wang L, Che Y, Wang F, Wang S, Gao S, Xue Q, Zhang Y, He J. Zhang C, et al. Among authors: wang f, wang l, wang s. Signal Transduct Target Ther. 2020 Sep 4;5(1):182. doi: 10.1038/s41392-020-00221-8. Signal Transduct Target Ther. 2020. PMID: 32883946 Free PMC article.

4

A three-lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy.

Zhang C, Zhang Z, Zhang G, Xue L, Yang H, Luo Y, Zheng X, Zhang Y, Yuan Y, Lei R, Yang Z, Zheng B, Zhang Z, Wang L, Che Y, Wang S, Wang F, Fang L, Zeng Q, Li J, Gao S, Xue Q, Sun N, He J. Zhang C, et al. Among authors: wang f, wang l, wang s. Clin Transl Med. 2020 Aug;10(4):e156. doi: 10.1002/ctm2.156. Clin Transl Med. 2020. PMID: 32898328 Free PMC article.

5

A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma.

Liu C, Wang S, Zheng S, Wang X, Huang J, Lei Y, Mao S, Feng X, Sun N, He J. Liu C, et al. Among authors: wang x, wang s. Cancer Biol Med. 2021 Apr 15;18(3):734-49. doi: 10.20892/j.issn.2095-3941.2020.0397. Online ahead of print. Cancer Biol Med. 2021. PMID: 33856140 Free PMC article.

6

Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma.

Liu C, Zheng S, Wang S, Wang X, Feng X, Sun N, He J. Liu C, et al. Among authors: wang x, wang s. Ther Adv Med Oncol. 2021 Apr 8;13:17588359211006949. doi: 10.1177/17588359211006949. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33889215 Free PMC article.

7

S100A7 as a potential diagnostic and prognostic biomarker of esophageal squamous cell carcinoma promotes M2 macrophage infiltration and angiogenesis.

Lu Z, Zheng S, Liu C, Wang X, Zhang G, Wang F, Wang S, Huang J, Mao S, Lei Y, Wang Z, Sun N, He J. Lu Z, et al. Among authors: wang x, wang f, wang z, wang s. Clin Transl Med. 2021 Jul;11(7):e459. doi: 10.1002/ctm2.459. Clin Transl Med. 2021. PMID: 34323409 Free PMC article.

8

TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2.

Wang F, Zhang C, Cheng H, Liu C, Lu Z, Zheng S, Wang S, Sun N, He J. Wang F, et al. Among authors: wang s. Cell Death Dis. 2021 Oct 2;12(10):901. doi: 10.1038/s41419-021-04155-z. Cell Death Dis. 2021. PMID: 34601488 Free PMC article.

9

Avoiding Absolute Quantification Trap: A Novel Predictive Signature of Clinical Benefit to Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer.

Liu C, Wang S, Zheng S, Xu F, Cao Z, Feng X, Wang Y, Xue Q, Sun N, He J. Liu C, et al. Among authors: wang y, wang s. Front Immunol. 2021 Nov 19;12:782106. doi: 10.3389/fimmu.2021.782106. eCollection 2021. Front Immunol. 2021. PMID: 34868057 Free PMC article.

10

Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer.

Liu C, Yang L, Xu H, Zheng S, Wang Z, Wang S, Yang Y, Zhang S, Feng X, Sun N, Wang Y, He J. Liu C, et al. Among authors: wang z, wang y, wang s. BMC Med. 2022 May 13;20(1):187. doi: 10.1186/s12916-022-02356-7. BMC Med. 2022. PMID: 35550592 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118,278 results

Search Page

Filters